An overview of Orphan Reinsurer and Benefit Managers groups, including potential challenges with the model and various model suggestions.
Donald Han
Advertisement
Articles by Donald Han
Advertisement
Latest Updated Articles
Improving Management of Gene and Cell TherapiesPublished: September 10th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx Is Live and Complicated
2
Veradermics Raises $256 Million in Upsized Initial Public Offering
3
Novo Nordisk Releases 2025 Financial Report and 2026 Sales and Operations Profit Outlook
4
FDA Approves Vybrique to Treat Adult Men with Erectile Dysfunction
5